Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 28   

Articles published

GSK 1,467.52 -0.98 (-0.07%)
price chart
Glaxo Pursues Hostile Offer
GlaxoSmithKline PLC took its unsolicited $2.6 billion bid for Human Genome Sciences Inc. directly to the biotech's shareholders through a tender offer, a hostile move that will test Glaxo's long-standing partnership with the smaller firm.
GSK, Valeant Dodge Sham Patent Suit Claims In Wellbutrin Row
Law360, New York (May 11, 2012, 4:56 PM EDT) -- A Pennsylvania federal judge on Friday granted a move by GlaxoSmithKline PLC and Valeant Pharmaceuticals International to toss claims brought by purchasers of depression medication Wellbutrin XL in ...
Glaxo Scientist, Surgeon Targeting Historic British Hockey Gold
MacLeod, 27, also worked for GlaxoSmithKline Plc, the U.K.'s biggest drugmaker, as a sports scientist on its Lucozade energy drink.
Billions of dollars in taxes hang in balance at top court
A nearly 20-year battle between global drug giant GlaxoSmithKline Inc. and the Canada Revenue Agency, now being weighed by the Supreme Court of Canada, could end up rewriting the rules that allow multinationals to shift some of their profits out of ...
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
... the Future Market 707.2 Future Market Competition Scenario 708 Hepatitis B Therapeutics - Future Players 728.1 Introduction 728.2 Company Profiles 728.2.1 Bristol-Myers Squibb Company 728.2.2 Gilead Sciences 748.2.3 GlaxoSmithKline Plc 758.2.4 F.
Morning News Updates: AOL, Inc. (NYSE:AOL) Reported A Surge in Q1
InterContinental Hotels Group PLC (ADR) (NYSE:IHG), the world's largest provider of hotel rooms, reported a 5.4 percent rise in first quarter operating profits to $118 million, compared with consensus estimates of $116 million.
Market & Company News: Updates on EBAY, JCP, BKS, DELL, MSFT, GMCR
GlaxoSmithKline plc (ADR) (NYSE:GSK), AstraZeneca plc (ADR) (NYSE:AZN), Johnson & Johnson (NYSE:JNJ) and Sanofi SA (ADR) (NYSE:SNY) will collaborate in a �180 million research project to tackle growing threat from bugs' resistance to antibiotics.
Abbott Laboratories settles Depakote case for $1.6 billion
In November, GlaxoSmithKline PLC said it would pay the U.S. government $3 billion to settle civil and criminal charges for illegal marketing of its diabetes drug Avandia and others.
Pronova Defeats Teva, Par In Lovaza Patent Suit
Law360, Los Angeles (May 29, 2012, 10:06 PM EDT) -- A Delaware federal judge ruled Tuesday that Teva Pharmaceuticals USA Inc. and Par Pharmaceutical Inc. infringed two Pronova Biopharma Norge AS patents when they filed applications to sell a ...
Study: J&J's Zytiga Can Eliminate Some Prostate Tumors
--A combination of GlaxoSmithKline PLC's experimental drugs dabrafenib and trametinib stalled progression of advanced melanoma, a deadly form of skin cancer.